TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Distance actively covered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ipsilateral local recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Mean number of FMF-attacks per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day major adverse clinical events (MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Hospitalization for Heart Failure (HF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in chronic knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: post-prandial glucose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mental Help-Seeking Intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental Help-Seeking Behaviour
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Feasibility of FES sleeve for activities of daily living
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of victimization
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: anterior chamber inflammation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: range of inflammatory chorioretinal and/or retinal vascular lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of progenitor cell delivery
Endpoint domain: Adverse events/effects
Primary endpoint: BEAT-Calci Wound Assessment Scale (BCWAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Pediatric Quality of Life Multidimensional Fatigue Scale (PedsQL-MFS) score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Intestinal microbiota diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intestinal microbiota abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants adapting to BBTI
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Change in Sleep Disturbance Symptoms Measured by Pittsburgh Sleep Quality Index (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Myasthenia Gravis Impairment Index (MGII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of chronic orofacial pain of muscular origin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limbal ischaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of pain resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of interruptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average duration of speaking turn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VISTA expression in PBMCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of transplant-associated thrombotic microangiopathy (TA-TMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: R2* values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in well-being perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pennsylvania Shoulder Score (PENN)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Best overall response (BOR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cold temperature deflection point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient adherence to additional weekend physiotherapy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Response on Hamilton Rating Scale for Depression-17
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Remission on Hamilton Rating Scale for Depression-17
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prognostic impact of ctDNA on mortality
Endpoint domain: Mortality/survival
Primary endpoint: Mean change in Body Mass Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Leuven Postprandial Distress scale (LPDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Packed red blood cells (pRBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevalence of Participants With Intestinal Parasitic Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean Soluble CD14 (sCD14) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Soluble CD163 (sCD163) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Intestinal Fatty-acid Binding Protein (I-FABP) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in sCD14 Levels Pre- and Post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in the WSRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The rate of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Nocturia disappears or improves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Photopic Binocular DCNVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Assessment Upper Extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Box and Block Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Nine Hole Peg Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in percent time in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in insulinogenic index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in total body fat mass (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bite lesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantification of anti-C1s autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Right Ventricle to Left Ventricle (RV/LV) Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Substance-related problems
Endpoint domain: Adverse events/effects
Primary endpoint: Adequate labour analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Motor Evoked Potential Variance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in Motor Evoked Potential Amplitudes from 4mA and 2mA Stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Literacy of Suicide Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy Perception Scale For Suicide Risk Management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The Stigma of Suicide Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fatty acids concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical Response rate at week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and Severity of Adverse Events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Sexual health satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pathological mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Related Tennis Elbow Evaluation (PRTEE) pain in affected arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Related Tennis Elbow Evaluation (PRTEE) functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Visual analog scale (VAS) pain with resisted wrist extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICI-dependent systemic immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of TBE in pediatric patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: maximum plasma concentration of GB1211 (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to reach Cmax GB1211 (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the plasma concentration-time curve of GB1211 (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of verbs and objects correctly named
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: ED 50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum concentrations of MT-3534
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate from a resting ECG recording
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart rate from a 5-minute ECG recording
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: S-warfarin Maximum Plasma Concentration [Cmax]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midazolam Maximum Plasma Concentration [Cmax]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S-warfarin Area under the curve[AUC0-inf]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midazolam Area under the curve[AUC0-inf]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-Free Survival (PFS) at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Assay Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of seroprotection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Primary Lesion Target Patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Discontinuation symptom load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complete aneurysm occlusion in 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of parent artery stenosis in 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Patient prognosis in 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Change from Baseline weight at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time from the end of the surgery to leaving the OR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: resorption rate of the injected fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Adverse Events Related to Hepatic Failure, Hepatic Dysfunction, and Pancreatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Adverse Events Leading to Permanent Treatment Discontinuation with Cabozantinib Tablets
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Grade 3 or higher Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Longterm fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Post-dialysis fatigue-diary
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from baseline Pain at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Oswestry Disability Index for functional status at 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline Roland Morris Disability Questionnaire at 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ability to prenatally deflate the Smart-TO balloon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of discrepancies between classifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of 3D printed casts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of newborns with an Apgar score of less than 7 at 5 minutes after parturition
Endpoint domain: Adverse events/effects
Primary endpoint: patient-reported health-related quality of life Physical Health
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: patient-reported health-related quality of life Mental health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-experienced quality of care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in percent body fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of participants with one or more Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Changes in Safety Laboratory Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effects of antenatal corticosteroids on neonatal outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hepatic Fat Fraction (HFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severity of neurological damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional recovery outcomes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Severity of symptoms in patients with depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference in amplitude of the N100 ERP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in latency of the N100 ERP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in amplitude of the P300 ERP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in latency of the P300 ERP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in amplitude of the N400 ERP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in latency of the N400 ERP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Level of satisfaction with the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Level of compliance with the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes of sedentary behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with treatment-related adverse events (TRAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Minimal Residual Disease (MRD)-negative subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Median progression-free survival (mPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Intellectual ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Central executive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Verbal working memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual-spatial working memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Chinese word reading
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in Brief Pain Inventory-Short Form (BPI-SF) score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Inclusion of Others in Self (IOS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intervention feasibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intervention appropriateness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intervention safety
Endpoint domain: Adverse events/effects
Primary endpoint: Hearing test Otoacoustic Emission (TEOAE and DPOAE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in breathlessness intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Structural Integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of treatment in patients with COVID-19 and de novo diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Induced sputum analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in thigh skin temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional hamstring flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RT-qPCR Cycle threshold (Ct) value of mineralocorticoid receptor-regulated gene mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with worsening Heart Failure events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to first worsening Heart Failure event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety as Assessed by Grade 3-4 Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: MPR Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRD negative Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Insurance Literacy Measure (HILM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COmprehensive Score for financial Toxicity (COST)
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Labour pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of cardiac arrest
Endpoint domain: Mortality/survival
Primary endpoint: Concentration of PK CAR positive T cells in peripheral blood and bone marrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Gastrostomy (G)-tube placement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rate of positive IgG serology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Levels of Alpha-synuclein and Human Neurofilament Light
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Level of antioxidant: Superoxide Dismutase (SOD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient's average pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of VI-RADS scoring system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of different cells per each phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: density of each phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: fraction of proliferative/active cells of each phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants That Recommend Feeding Therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants That Recommend Referral to Other Providers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants That Recommend Referral by Specialty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: (Z)-endoxifen steady-state plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endocrine sensitive disease rate based on Ki-67 percent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes